Dr. Samim Ali Mondal

Dr. Samim Ali Mondal
Department: 
Endocrinology
Designation: 
Assistant Professor
Academic Qualifications: 

M.Sc., Ph.D.
Biography

Dr. Samim Ali Mondal serves as an Assistant Professor at the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in Pondicherry, India. Motivated by his passion for patient-oriented translational research, he has dedicated his career to exploring Metabolic Diseases, a field he finds deeply engaging and rewarding. His specific interests lie in translational research related to conditions such as Diabetes, NAFLD, NASH, and NASH-driven hepatocellular carcinoma (HCC).

Following the completion of his Ph.D. from the University of Calcutta in 2019, he pursued further training in the United States. He undertook postdoctoral studies at the University of Oklahoma Health Science Center (OUHSC) before transitioning to the Oklahoma Medical Research Foundation (OMRF) as a postdoctoral fellow. His focus during this time was on investigating how sex hormones modulate liver metabolism and chronic liver diseases. Dr. Mondal possesses extensive experience working with both human subjects and genetically modified animals. Dr. Mondal has presented his research findings at numerous international conferences and has been honored with awards from national and international organizations. His research efforts have resulted in numerous publications in esteemed national and international peer-reviewed journals, including book chapters and reviews. He is an active member of several international societies, serving as a reviewer for various international peer-reviewed journals.

His current research focus is on studying metabolically unhealthy livers and their potential impact on the other organs. Also to develop therapeutic strategies that can target metabolic signaling pathways to mitigate metabolic diseases.

Publication: 

Publication: 

https://www.ncbi.nlm.nih.gov/myncbi/samim%20ali.mondal.1/bibliography/public/

  1. Isola JV, Ocañas SR, Hubbart CR, Ko S, Mondal SA, Hense JD, Carter HN, Schneider A, Kovats S, Alberola-Ila J, Freeman WM. A single-cell atlas of the aging mouse ovary. Nature Aging. 2024 Jan 10:1-8.
  2. Bubak MP, Mann SN, Borowik AK, Pranay A, Batushansky A, Vieira de Sousa Neto I, Ali Mondal SA, Doidge SM,.., Stout MB, Miller BF. 17α-estradiol Alleviates High-Fat Diet-Induced Inflammatory and Metabolic Dysfunction in Skeletal Muscle of Male and Female Mice. Am J Physiol Endocrinol Metab. 2024 Jan 10. doi: 10.1152/ajpendo.00215.2023. Epub ahead of print. PMID: 38197793.
  3. Mondal, S. A., Mann, S. N., van der Linden, C., Sathiaseelan, R., Kamal, M., Das, S., ... & Stout, M. B. (2023). Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice. Scientific Reports, 13(1), 9841.
  4. Ali Mondal, S., Sathiaseelan, R., Mann, S. N., Kamal, M., Luo, W., Saccon, T. D., ... & Stout, M. B. (2023). 17α-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice. American Journal of Physiology-Endocrinology and Metabolism, 324(2), E120-E134.
  5. Das, S., Chattopadhyay, D., Chatterjee, S. K., Mondal, S. A., Majumdar, S. S., Mukhopadhyay, S., ... & Mukherjee, S. (2021). Increase in PPARγ inhibitory phosphorylation by Fetuin—A through the activation of Ras-MEK-ERK pathway causes insulin resistance. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease,1867(4), 166050.
  6. Ansere, V. A., Ali-Mondal, S., Sathiaseelan, R., Garcia, D. N., Isola, J. V., Henseb, J. D., ... & Freeman, W. M. (2021). Cellular hallmarks of aging emerge in the ovary prior to primordial follicle depletion. Mechanisms of ageing and development, 194, 111425.
  7. Dutta, D., Mondal, S. A., Kumar, M., Hasanoor Reza, A. H., Biswas, D., Singh, P., ... & Mukhopadhyay, S. (2014). Serum fetuin‐A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. Diabetic medicine, 31(12), 1594-1599.
  8. Mukhopadhyay, S., Mondal, S. A., Kumar, M., & Dutta, D. (2014). Proinflammatory and antiinflammatory attributes of fetu Iν-A: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome. Endocrine Practice, 20(12), 1345-1351.
  9. Dutta, D., Mondal, S. A., Choudhuri, S., Maisnam, I., Reza, A. H. H., Bhattacharya, B., ... & Mukhopadhyay, S. (2014). Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: an open label randomized prospective study from Eastern India. Diabetes research and clinical practice, 103(3), e18-e23.
  10. Dutta, D., Choudhuri, S., Mondal, S. A., Maisnam, I., Reza, A. H. H., Ghosh, S., ... & Mukhopadhyay, S. (2013). Tumor necrosis factor alpha− 238G/a (rs 361525) gene polymorphism predicts progression to type-2 diabetes in an eastern Indian population with prediabetes. Diabetes research and clinical practice, 99(3), e37-e41.
Country: 
India